Mast cell inhibitor cromolyn increases blood clotting and hypoxia in murine breast cancer.
about
Degranulating mast cells in fibrotic regions of human tumors and evidence that mast cell heparin interferes with the growth of tumor cells through a mechanism involving fibroblastsThe relationship between breast cancer molecular subtypes and mast cell populations in tumor microenvironment.Molecular imaging of tumor-infiltrating macrophages in a preclinical mouse model of breast cancer.Effect of cromolyn on S100P interactions with RAGE and pancreatic cancer growth and invasion in mouse models.Mast cell restricted mouse and human tryptase·heparin complexes hinder thrombin-induced coagulation of plasma and the generation of fibrin by proteolytically destroying fibrinogenEvidence questioning cromolyn's effectiveness and selectivity as a 'mast cell stabilizer' in mice.Conjugated linoleic acid induces mast cell recruitment during mouse mammary gland stromal remodeling.Role of mast cells and protease-activated receptor-2 in cyclooxygenase-2 expression in urothelial cells.Alterations in mast cell frequency and relationship to angiogenesis in the rat mammary gland during windows of physiologic tissue remodeling.The significant role of mast cells in cancer.The Hidden Side of Disodium Cromolyn: from Mast Cell Stabilizer to an Angiogenic Factor and Antitumor Agent.Improved immunohistochemical method for detecting hypoxia gradients in mouse tissues and tumors.Contribution of Adipose Tissue to Development of Cancer.Anti-angiogenic effects of interleukin-12 delivered by a novel hyperthermia induced gene construct.Mast Cell, the Neglected Member of the Tumor Microenvironment: Role in Breast Cancer.
P2860
Q24814173-4A2C4CA1-0A1F-478D-9CB6-7BD03C36BD5BQ33607142-D9DF0014-4BBE-4100-B66A-DE460ADFD3E5Q35227499-F851755F-E59F-43E4-928E-58F89F782A03Q35702968-2BCB93B3-580B-46D7-90F5-EAF00CD98A6EQ35868279-10281AAA-D9C6-45C0-9F8A-6E0DA5E8EC59Q36632214-9E14A33D-3979-47AD-A048-D7FEA507E4F0Q36748199-F9DFFBFF-9187-4CC9-8C73-7F696058684FQ37391866-315340D1-E596-4596-92DB-4F40D9F5C5EFQ37692623-74E1774A-B9CC-42F0-84B0-37BB7F3CC137Q37834484-C78CA6CD-BF91-4FBB-9F4B-796C87D2F336Q38735264-CD20B3CD-DFA1-41E6-9DC1-72FE6D030FDDQ44901206-EE6A819F-6BF3-4E27-8CE5-A1809F7D6753Q49164235-B51DB384-2F0D-45F5-B593-CCC2920587FEQ54573260-ACBDF537-A9BB-4D51-9840-33E736BCD743Q55483878-A381C229-8E81-454C-8F31-BC96E9C19A8E
P2860
Mast cell inhibitor cromolyn increases blood clotting and hypoxia in murine breast cancer.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Mast cell inhibitor cromolyn i ...... poxia in murine breast cancer.
@en
Mast cell inhibitor cromolyn i ...... poxia in murine breast cancer.
@nl
type
label
Mast cell inhibitor cromolyn i ...... poxia in murine breast cancer.
@en
Mast cell inhibitor cromolyn i ...... poxia in murine breast cancer.
@nl
prefLabel
Mast cell inhibitor cromolyn i ...... poxia in murine breast cancer.
@en
Mast cell inhibitor cromolyn i ...... poxia in murine breast cancer.
@nl
P356
P1476
Mast cell inhibitor cromolyn i ...... poxia in murine breast cancer.
@en
P2093
Mark A Corwin
Michael Samoszuk
P304
P356
10.1002/IJC.11340
P577
2003-10-01T00:00:00Z